157 related articles for article (PubMed ID: 37389442)
1. Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study.
Crump C; Stattin P; Brooks JD; Sundquist J; Edwards AC; Sieh W; Sundquist K
JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37389442
[TBL] [Abstract][Full Text] [Related]
2. Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study.
Crump C; Stattin P; Brooks JD; Sundquist J; Bill-Axelson A; Edwards AC; Sundquist K; Sieh W
Eur Urol; 2023 Sep; 84(3):263-272. PubMed ID: 37169640
[TBL] [Abstract][Full Text] [Related]
3. Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study.
Crump C; Stattin P; Brooks JD; Sundquist J; Edwards AC; Sundquist K; Sieh W
J Natl Cancer Inst; 2024 May; 116(5):745-752. PubMed ID: 38060258
[TBL] [Abstract][Full Text] [Related]
4. Mortality Risks Associated with Depression in Men with Prostate Cancer.
Crump C; Stattin P; Brooks JD; Sundquist J; Sieh W; Sundquist K
Eur Urol Oncol; 2024 Apr; ():. PubMed ID: 38575410
[TBL] [Abstract][Full Text] [Related]
5. Risk of fracture incidence in prostate cancer survivors: a nationwide cohort study in South Korea.
Shin HB; Park HS; Yoo JE; Han K; Park SH; Shin DW; Park J
Arch Osteoporos; 2020 Jul; 15(1):110. PubMed ID: 32700143
[TBL] [Abstract][Full Text] [Related]
6. Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.
Shore R; Zhang J; Ye W; Stattin P; Lindblad M
Cancer Causes Control; 2023 Nov; 34(11):949-961. PubMed ID: 37341814
[TBL] [Abstract][Full Text] [Related]
7. Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer.
Nguyen C; Lairson DR; Swartz MD; Du XL
Pharmacotherapy; 2018 Oct; 38(10):999-1009. PubMed ID: 30080934
[TBL] [Abstract][Full Text] [Related]
8. Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy.
Raldow AC; Zhang D; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
Brachytherapy; 2015; 14(6):781-7. PubMed ID: 26361718
[TBL] [Abstract][Full Text] [Related]
9. Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea.
Kang J; Shin DW; Han K; Park SH; Lee WG; Yoo JE; Woo SH; Park J
Curr Probl Cancer; 2020 Dec; 44(6):100578. PubMed ID: 32360240
[TBL] [Abstract][Full Text] [Related]
10. Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study.
Ng HS; Koczwara B; Roder D; Vitry A
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):403-410. PubMed ID: 29720722
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk prostate cancer and the risk of all-cause and prostate cancer-specific mortality.
Bitterman DS; Chen MH; Wu J; Renshaw AA; Loffredo M; Kantoff PW; Small EJ; D'Amico AV
Cancer; 2021 Aug; 127(15):2623-2630. PubMed ID: 33823065
[TBL] [Abstract][Full Text] [Related]
12. Mortality and incidence of new primary cancers in men with prostate cancer: a Danish population-based cohort study.
Cronin-Fenton DP; Antonsen S; Cetin K; Daniels A; Borre M; Acquavella J; Lash TL
Cancer Epidemiol; 2013 Oct; 37(5):562-8. PubMed ID: 23830884
[TBL] [Abstract][Full Text] [Related]
13. Risk of Ischemic Heart Disease and Stroke in Prostate Cancer Survivors: A Nationwide Study in South Korea.
Shin DW; Han K; Park HS; Lee SP; Park SH; Park J
Sci Rep; 2020 Jun; 10(1):10313. PubMed ID: 32587285
[TBL] [Abstract][Full Text] [Related]
14. Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease.
Keane FK; Chen MH; Zhang D; Moran BJ; Braccioforte MH; D'Amico AV
Cancer; 2015 Aug; 121(16):2713-9. PubMed ID: 25925789
[TBL] [Abstract][Full Text] [Related]
15. Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.
Pinthus JH; Duivenvoorden WCM; Klotz L; Mukherjee SD; Siemens DR; Niazi T; Fradet V; Foster W; Duceppe E; Taussky D; Hamilton R; Lavallée L; Brown I; Chin J; Gopaul D; Wassef A; Kassouf W; Davis M; Violette PD; Agapay S; Balasubramanian K; Mian R; Rangarajan S; Sener A; Shayegan B; Devereaux PJ; Leong DP
J Urol; 2022 May; 207(5):1020-1028. PubMed ID: 34978211
[TBL] [Abstract][Full Text] [Related]
16. Alcohol use disorder and non-fatal suicide attempt: findings from a Swedish National Cohort Study.
Edwards AC; Ohlsson H; Mościcki E; Crump C; Sundquist J; Kendler KS; Sundquist K
Addiction; 2022 Jan; 117(1):96-105. PubMed ID: 34159695
[TBL] [Abstract][Full Text] [Related]
17. Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.
Gillessen S; Templeton A; Marra G; Kuo YF; Valtorta E; Shahinian VB
J Natl Cancer Inst; 2010 Dec; 102(23):1760-70. PubMed ID: 21068432
[TBL] [Abstract][Full Text] [Related]
18. Mortality in adult children of parents with alcohol use disorder: a nationwide register study.
Westman J; Jayaram-Lindström N; Kane K; Franck J; Gissler M
Eur J Epidemiol; 2022 Aug; 37(8):815-826. PubMed ID: 35737206
[TBL] [Abstract][Full Text] [Related]
19. Risk of severe mood and anxiety disorders in the adult children of parents with alcohol use disorder: a nationwide cohort study.
Kane K; Westman J; Franck J; Gissler M
J Epidemiol Community Health; 2024 Apr; ():. PubMed ID: 38688702
[TBL] [Abstract][Full Text] [Related]
20. No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study.
Kao LT; Lin HC; Chung SD; Huang CY
Asian J Androl; 2017; 19(4):414-417. PubMed ID: 27232853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
